These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
439 related articles for article (PubMed ID: 31109983)
21. The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*. Jamal JA; Udy AA; Lipman J; Roberts JA Crit Care Med; 2014 Jul; 42(7):1640-50. PubMed ID: 24674926 [TBL] [Abstract][Full Text] [Related]
22. Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy. Jang SM; Infante S; Abdi Pour A Pharmacy (Basel); 2020 Feb; 8(1):. PubMed ID: 32046092 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic/pharmacodynamic considerations for the optimization of antimicrobial delivery in the critically ill. Tsai D; Lipman J; Roberts JA Curr Opin Crit Care; 2015 Oct; 21(5):412-20. PubMed ID: 26348420 [TBL] [Abstract][Full Text] [Related]
24. Antimicrobial Disposition During Pediatric Continuous Renal Replacement Therapy Using an Ex Vivo Model. Purohit PJ; Elkomy MH; Frymoyer A; Sutherland SM; Drover DR; Hammer GB; Su F Crit Care Med; 2019 Sep; 47(9):e767-e773. PubMed ID: 31306179 [TBL] [Abstract][Full Text] [Related]
25. Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study. Broeker A; Wicha SG; Dorn C; Kratzer A; Schleibinger M; Kees F; Heininger A; Kees MG; Häberle H Crit Care; 2018 Dec; 22(1):341. PubMed ID: 30558639 [TBL] [Abstract][Full Text] [Related]
26. Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy. Economou CJP; Wong G; McWhinney B; Ungerer JPJ; Lipman J; Roberts JA Int J Antimicrob Agents; 2017 May; 49(5):589-594. PubMed ID: 28341612 [TBL] [Abstract][Full Text] [Related]
27. Influence of renal replacement therapy on pharmacokinetics in critically ill patients. Bugge JF Best Pract Res Clin Anaesthesiol; 2004 Mar; 18(1):175-87. PubMed ID: 14760881 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and Pharmacodynamics of Antimicrobials in Critically Ill Patients. Owen EJ; Gibson GA; Buckman SA Surg Infect (Larchmt); 2018; 19(2):155-162. PubMed ID: 29272204 [TBL] [Abstract][Full Text] [Related]
31. The impact of continuous renal replacement therapy on antibiotic pharmacokinetics in critically ill patients. Fiore M; Peluso L; Taccone FS; Hites M Expert Opin Drug Metab Toxicol; 2021 May; 17(5):543-554. PubMed ID: 33733979 [No Abstract] [Full Text] [Related]
32. [Dose adjustment of anti-infective drugs in patients with renal failure and renal replacement therapy in intensive care medicine : Recommendations from the renal section of the DGIIN, ÖGIAIN and DIVI]. Czock D; Schwenger V; Kindgen-Milles D; Joannidis M; John S; Schmitz M; Jörres A; Zarbock A; Oppert M; Kielstein JT; Willam C Med Klin Intensivmed Notfmed; 2018 Jun; 113(5):384-392. PubMed ID: 29546450 [TBL] [Abstract][Full Text] [Related]
33. Practical considerations for individualizing drug dosing in critically ill adults receiving renal replacement therapy. Kanji S; Roger C; Taccone FS; Muller L Pharmacotherapy; 2023 Nov; 43(11):1194-1205. PubMed ID: 37491976 [TBL] [Abstract][Full Text] [Related]